vs
Side-by-side financial comparison of FEDERAL AGRICULTURAL MORTGAGE CORP (AGM) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
FEDERAL AGRICULTURAL MORTGAGE CORP is the larger business by last-quarter revenue ($107.5M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 6.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.1%).
The Federal Agricultural Mortgage Corporation, also known as Farmer Mac, is a stockholder-owned, federally chartered corporation established by the U.S. Congress in 1988 under the Agricultural Credit Act of 1987. It was created to establish a secondary market for agricultural real estate and housing mortgage loans, to increase liquidity and the availability of long-term, stable credit for farmers, ranchers, and rural communities.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
AGM vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $107.5M | $62.1M |
| Net Profit | — | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | 56.3% | -9.0% |
| Net Margin | — | -70.9% |
| Revenue YoY | 6.1% | 8.1% |
| Net Profit YoY | — | -557.1% |
| EPS (diluted) | $3.69 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $107.5M | $62.1M | ||
| Q3 25 | $104.0M | $52.3M | ||
| Q2 25 | $102.6M | $45.6M | ||
| Q1 25 | $94.3M | $41.5M | ||
| Q4 24 | $101.3M | $57.5M | ||
| Q3 24 | $90.3M | $51.5M | ||
| Q2 24 | $89.9M | $46.6M | ||
| Q1 24 | $93.7M | $44.9M |
| Q4 25 | — | $-44.1M | ||
| Q3 25 | $55.0M | $-5.5M | ||
| Q2 25 | $54.8M | $-5.6M | ||
| Q1 25 | $49.7M | $-11.4M | ||
| Q4 24 | $56.5M | $9.6M | ||
| Q3 24 | $49.8M | $941.0K | ||
| Q2 24 | $47.1M | $-10.4M | ||
| Q1 24 | $53.7M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | 56.3% | -9.0% | ||
| Q3 25 | 64.1% | -17.6% | ||
| Q2 25 | 63.8% | -23.3% | ||
| Q1 25 | 66.9% | -36.1% | ||
| Q4 24 | 67.5% | 5.2% | ||
| Q3 24 | 69.0% | -8.2% | ||
| Q2 24 | 65.9% | -18.3% | ||
| Q1 24 | 72.8% | -23.9% |
| Q4 25 | — | -70.9% | ||
| Q3 25 | 52.9% | -10.5% | ||
| Q2 25 | 53.4% | -12.2% | ||
| Q1 25 | 52.6% | -27.5% | ||
| Q4 24 | 55.8% | 16.8% | ||
| Q3 24 | 55.2% | 1.8% | ||
| Q2 24 | 52.4% | -22.4% | ||
| Q1 24 | 57.4% | -13.8% |
| Q4 25 | $3.69 | — | ||
| Q3 25 | $4.44 | — | ||
| Q2 25 | $4.48 | — | ||
| Q1 25 | $4.01 | — | ||
| Q4 24 | $4.62 | — | ||
| Q3 24 | $3.86 | — | ||
| Q2 24 | $3.68 | — | ||
| Q1 24 | $4.28 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $90.9M |
| Total DebtLower is stronger | $30.8B | — |
| Stockholders' EquityBook value | $1.7B | $341.7M |
| Total Assets | $35.4B | $461.5M |
| Debt / EquityLower = less leverage | 17.93× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | $842.1M | $162.3M | ||
| Q2 24 | $923.0M | $177.9M | ||
| Q1 24 | $745.1M | $168.8M |
| Q4 25 | $30.8B | — | ||
| Q3 25 | $29.2B | — | ||
| Q2 25 | $28.9B | — | ||
| Q1 25 | $28.0B | — | ||
| Q4 24 | $27.5B | — | ||
| Q3 24 | $27.2B | — | ||
| Q2 24 | $26.8B | — | ||
| Q1 24 | $26.8B | — |
| Q4 25 | $1.7B | $341.7M | ||
| Q3 25 | $1.7B | $378.6M | ||
| Q2 25 | $1.5B | $377.6M | ||
| Q1 25 | $1.5B | $379.6M | ||
| Q4 24 | $1.5B | $395.7M | ||
| Q3 24 | $1.5B | $385.5M | ||
| Q2 24 | $1.5B | $389.1M | ||
| Q1 24 | $1.5B | $392.6M |
| Q4 25 | $35.4B | $461.5M | ||
| Q3 25 | $33.4B | $494.9M | ||
| Q2 25 | $33.0B | $493.3M | ||
| Q1 25 | $31.8B | $482.6M | ||
| Q4 24 | $31.3B | $499.5M | ||
| Q3 24 | $30.6B | $491.2M | ||
| Q2 24 | $30.2B | $483.7M | ||
| Q1 24 | $29.8B | $492.1M |
| Q4 25 | 17.93× | — | ||
| Q3 25 | 17.31× | — | ||
| Q2 25 | 18.70× | — | ||
| Q1 25 | 18.39× | — | ||
| Q4 24 | 18.48× | — | ||
| Q3 24 | 18.60× | — | ||
| Q2 24 | 17.87× | — | ||
| Q1 24 | 18.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.1M | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | 0.0% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.1M | $-771.0K | ||
| Q3 25 | $74.2M | $-3.9M | ||
| Q2 25 | $-47.7M | $108.0K | ||
| Q1 25 | $-49.8M | $-125.0K | ||
| Q4 24 | $612.6M | $2.0M | ||
| Q3 24 | $-44.4M | $13.2M | ||
| Q2 24 | $56.1M | $6.2M | ||
| Q1 24 | $233.3M | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | $607.4M | $1.1M | ||
| Q3 24 | $-44.4M | $12.2M | ||
| Q2 24 | $52.6M | $5.2M | ||
| Q1 24 | $231.7M | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | 599.8% | 1.9% | ||
| Q3 24 | -49.2% | 23.7% | ||
| Q2 24 | 58.5% | 11.0% | ||
| Q1 24 | 247.3% | 7.6% |
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 0.0% | 3.5% | ||
| Q1 25 | 0.0% | 2.0% | ||
| Q4 24 | 5.2% | 1.6% | ||
| Q3 24 | 0.1% | 2.0% | ||
| Q2 24 | 4.0% | 2.3% | ||
| Q1 24 | 1.7% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | -0.87× | — | ||
| Q1 25 | -1.00× | — | ||
| Q4 24 | 10.84× | 0.21× | ||
| Q3 24 | -0.89× | 14.05× | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 4.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGM
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
